United Therapeutics holds the cleaner structural position, with profitability as the main driver and stability adding further support. Evolution AB (publ) still has the edge on growth, which keeps the comparison from looking entirely one-sided. On the market side, United Therapeutics is in better shape — its trend is intact while Evolution AB (publ)'s trend has broken down. That puts structure and market broadly in agreement — United Therapeutics's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (EVO.ST: STOXX 600, UTHR: Russell 1000).
Most of the separation is still concentrated in profitability. United Therapeutics Corporation leads by 15 points on the overall comparison score.
This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.
A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.
The clearest structural overlap shows up in margin trend and revenue growth trajectory.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
United Therapeutics Corporation occupies the cheaper side of the setup map, although Evolution AB (publ) still holds the stronger structural profile.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where EVO.ST and UTHR each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The profitability gap is very wide, with the stronger side earning materially better operating marks.
Evolution AB (publ) still carries lower volatility exposure — that difference is real enough to prevent the comparison from becoming one-sided.
Profitability is the clearest driver of the lead, with stability adding further support — though growth still provides a real counterweight.
Break down the EVO.ST vs UTHR comparison across all dimensions with the full interactive tool.
Explore how EVO.ST and UTHR each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.